鶹ýӰ

Meeting Coverage

ACC

American College of Cardiology

FFR-Guided Complete Revascularization Did Not Improve Outcomes in MI Patients

Compared with PCI of the culprit lesion, no difference in death, MI, unplanned revascularization

ACC over a photo of Georgia World Congress Center in Atlanta, GA

Latest ACC Meeting Coverage

Novel Biannual Antihypertensive Shows Potential for Combination Therapy

Drug might be most effective with a diuretic, according to suggestive data from a phase II trial

April 9, 2024
For PCI, Intravascular Ultrasound Guidance Bests Angiography Guidance

Randomized trial shows better outcomes for patients with acute coronary syndromes

April 9, 2024
Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock

First trial in a quarter-century to show mortality benefit in this desperately ill group

April 9, 2024
Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BP

For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP

April 9, 2024
Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot

Patient acceptance could be an advantage, researchers say

April 9, 2024
Early Win for Preemptive Stents on Vulnerable Coronary Plaque

Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial

April 8, 2024
Self-Selection for Statin Appears Safe, Effective

Nonprescription rosuvastatin pans out in a second trial

April 8, 2024
With Ticagrelor, Aspirin May Not Be Needed After PCI for Acute Coronary Syndrome

Researcher suggests findings are robust enough to change practice guidelines

April 8, 2024
Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina

After ORBITA-COSMIC, Reducer device's mechanism of benefit remains unknown

April 8, 2024
Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial

HDL therapeutic failed to reduce risk of MI, stroke, or cardiovascular death in high-risk group

April 8, 2024
Chelation Flops for Cardio Health After Heart Attack

TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial

April 8, 2024
Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients

Standard medications losing appeal amid more modern heart attack treatments

April 8, 2024
Antisense Drug Slashes High Triglycerides

Two trials show promise in moderate and extreme elevations

April 8, 2024
Self-Expanding Evolut Valves Edge Out Sapien in Majority-Female TAVR Trial

Two common devices go head to head in people with small aortic annuli

April 8, 2024